By Byron Raal, CAS Founder-Editor · Last updated 22 June 2026 · About the author
Match me to a vetted, independent compressed-air specialist. Free, no obligation.
Independent and vendor-neutral. We do not sell equipment.
TGA-regulated pharmaceutical compressed air in Australia follows PIC/S PE 009-17 (applied by the TGA from 1 September 2025) plus its Annex 1 for sterile manufacture. The Code does not prescribe a single ISO 8573-1 class; benchmarks are set by site contamination-control strategy. Industry consensus: Class 1.2.1 for direct product contact; oil-free compression + desiccant drying + 0.2 µm sterile membrane filtration.
What does TGA expect for compressed air in pharmaceutical manufacturing?
The Therapeutic Goods Administration adopts PIC/S Guide to GMP edition PE009-17 (applied in Australia from 1 September 2025). Annex 1 covers sterile manufacture and frames compressed air as a critical utility requiring qualification and validation against site-defined risk levels. Specific ISO 8573-1:2010 air-class targets are a site or manufacturer decision under PIC/S PE009, not a TGA prescription; industry practice typically aligns direct product contact air to Class 1.2.1 or 1.2.2 against PIC/S Annex 15 IQ/OQ/PQ documentation.
Introduction
Get the air quality wrong on a pharmaceutical line and you are not looking at a maintenance ticket, you are looking at a rejected batch, a recall, or a regulator on site. Compressed air in pharmaceutical manufacturing is not a commodity utility: it is a critical process input whose quality directly impacts product safety, batch viability, and regulatory standing. Australian pharmaceutical manufacturers operate under the Therapeutic Goods Administration (TGA), which has adopted the Pharmaceutical Inspection Co-operation Scheme (PIC/S) Guide to GMP (PE009-17) with effect from 1 September 2025. Under that framework, compressed air is treated as a critical utility whose contamination-risk controls (particulate, water, oil, microbiological) must be designed, qualified, and monitored per the site’s Contamination Control Strategy. Contamination failures (particle, oil, water, or microbial ingress) trigger batch rejection, product recalls, and potential regulatory enforcement action.
If you are a plant manager, quality assurance lead, process engineer, or facility planner tasked with specifying, validating, or troubleshooting pharmaceutical-grade compressed air systems in Australia, this guide is written for you. Our focus is infrastructure, regulatory compliance, and system design. CAS is an independent information resource that connects enquiries to qualified suppliers; we do not provide engineering consultation. The framework and standards references below equip you to brief your equipment supplier, validate your system, and maintain compliance throughout production.
Who Should Read This
- Plant managers and pharmaceutical facility operators
- Quality assurance and regulatory compliance teams
- Process and facilities engineers specifying or validating systems
- Equipment suppliers designing systems for Australian manufacturers
- Maintenance technicians responsible for system upkeep
Regulatory Framework: TGA, PIC/S and GMP Compliance
Here is what binds you. Australia’s Therapeutic Goods Administration enforces Good Manufacturing Practice (GMP) standards for pharmaceutical manufacturing under the Therapeutic Goods Act 1989. TGA’s GMP framework aligns with the PIC/S Guide to GMP (PE009-17, published 25 August 2023 and TGA-adopted from 1 September 2025), which means compliance with the PIC/S framework also satisfies TGA requirements. Compressed air is one of the critical utilities covered by the PIC/S Annex 1 utility and Contamination Control Strategy (CCS) requirements; it does not have a stand-alone TGA-published compressed-air specification document, so the air-quality specification, monitoring frequency, and acceptance criteria are set by the site’s quality system against the relevant product and process risk.
Key regulatory points:
- PIC/S Annex 1 (2023 revision, incorporated into PE009-17): requires a documented Contamination Control Strategy covering every utility that contacts the product or aseptic environment. Compressed air must be addressed inside the CCS, with risk assessments determining air-quality specifications at each point of use.
- ISO 8573-1 air purity: Pharmaceutical compressed air is typically validated against ISO 8573-1:2010 Class 1.2.1 or tighter inside the site’s PIC/S validation file. The required class is determined by the achieved purity at point of use against PIC/S Annex 1 contamination-control requirements (particulate, water, oil, microbiological) for the contact zone, not by product category alone. Aseptic, parenteral, and inhalation processing typically demands the most stringent classes. Verification across all axes uses the ISO 8573 series test methods: Part 4 for solid particle count (ISO 8573-4 and ISO 8573-8 are the compressed-air particle measurement references), Part 3 for water vapour humidity, Part 2 plus Part 5:2025 combined for total oil (aerosol plus vapour), and Part 7 for viable microbiological CFU.
- System validation: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) per PIC/S Annex 15. Suppliers must provide documented evidence of design, testing, and performance.
- Ongoing monitoring: In-use monitoring (pressure, dew point, filter differential pressure) follows the validated protocol, typically continuous or at daily intervals for direct-contact applications. Records are retained per the site quality system and applicable TGA retention requirements for the product class.
- Change management: Any modification to the compressed air system (new compressor, filter upgrade, dryer change, regulator adjustment) requires change control documentation and, where the change affects validated air quality, re-validation testing.
Air Quality Standards and ISO 8573-1 Classifications
ISO 8573-1 doesn’t tell you what class to run. Your process risk does. ISO 8573-1:2010 Part 1 defines air purity in three independent dimensions: solid particle count, water content (pressure dew point), and total oil concentration (aerosol plus liquid plus vapour). Each dimension is rated on its own scale (Class 0 to 9, with 0 being the most stringent user-defined class).
| ISO 8573-1 Class | Particles | Typical Pharmaceutical Use | Pressure Dew Point | Oil Content |
|---|---|---|---|---|
| Class 0 | User-defined (stricter than Class 1) | Inhalation products, parenteral drug container wash, aseptic processing where Class 1 is insufficient | User-defined (typically ≤-70°C or stricter) | User-defined (typically ≤0.01 mg/m³ or stricter) |
| Class 1 | 0.1 to 0.5 µm: ≤20,000/m³; 0.5 to 1.0 µm: ≤400/m³; 1.0 to 5.0 µm: ≤10/m³ | Parenteral fills, closed-system transfer, aseptic processing | ≤-70°C | ≤0.01 mg/m³ |
| Class 2 | 0.1 to 0.5 µm: ≤400,000/m³; 0.5 to 1.0 µm: ≤6,000/m³; 1.0 to 5.0 µm: ≤100/m³ | General powder manufacturing, tablet operations, encapsulation | ≤-40°C | ≤0.1 mg/m³ |
| Class 3 | 0.5 to 1.0 µm: ≤90,000/m³; 1.0 to 5.0 µm: ≤1,000/m³ | Non-critical operations, general facility air | ≤-20°C | ≤1 mg/m³ |
ISO 8573-1:2010 defines Class 0 as user-defined: stricter than Class 1, with exact particle, water and oil limits agreed between user and supplier and documented in the site quality specification. CAS does not propose universal numeric thresholds for Class 0 because the standard explicitly leaves them to site quality risk assessment.
TGA guidance does not mandate a universal ISO 8573-1 class for pharmaceutical compressed air. The required class is determined by the achieved purity at point of use against PIC/S Annex 1 contamination-control requirements for the contact zone, not by product category alone. Aseptic, parenteral, and inhalation processing typically demands the most stringent quality classes (Class 1 or stricter). Operations not involving direct product contact, such as utility air for tablet machinery actuation, packaging-line pneumatic cylinders, and instrument air, may justify a less stringent class against the contact-zone risk assessment.
System Design for Pharmaceutical Compressed Air
Compressor Selection and Oil-Free Requirements
The compressor is where you either close off the oil pathway or spend the rest of the system trying to. PIC/S PE 009-17 Annex 1 regulates the achieved gas quality (chemical, particulate, microbial), including oil and water content, taking into account the use and type of the gas and the design of the gas generation system. PIC/S does not prescribe a specific compressor lubrication architecture by name. Oil-free compressor technology is the most direct path to PIC/S-compliant air for direct-contact applications because it removes the oil contamination pathway at the source. Oil-injected (oil-lubricated) systems with adequate coalescing filtration and activated carbon can also achieve PIC/S-compliant utility air for non-direct-contact uses, provided the achieved oil content is verified by ISO 8573-2 (aerosol) and ISO 8573-5:2025 (vapour) testing. The decision turns on the achieved purity classification at point of use and the application’s contact zone, not on compressor lubrication architecture alone.
Oil-free screw compressors are the standard configuration for pharmaceutical sites that include direct-contact applications. Yes, you pay for it: they carry a typical 20 to 40 per cent capital premium over comparable oil-injected machines, but they eliminate the oil source entirely, which is the cheapest insurance you can buy against an oil-carryover batch loss. Some manufacturers offer water-cooled screw units, which improve thermal efficiency and reduce the drying burden downstream. Several state and federal schemes part-fund energy-efficiency upgrades of exactly this kind: check the current grants and incentives before you commit capital.
Aftercooler, Dryer, and Multi-Stage Filtration
One compressor on its own won’t get you to a pharmaceutical class. You need the full treatment train:
- Aftercooler: reduces discharge temperature from the compressor (typically 80 to 120°C down to 35 to 45°C), condensing bulk moisture. Essential for effective downstream drying.
- Coarse filter (Stage 1): removes particles ≥10 µm. Protects the dryer and downstream equipment from rapid fouling.
- Refrigerated or desiccant dryer: reduces dew point to specification. Because fundamental thermodynamic phase-change constraints prevent refrigerated evaporator coils from operating below approximately +3°C without freezing condensate and rupturing the heat exchanger, refrigerated dryers achieve Class 4 (+3°C pressure dew point) at most. Pharmaceutical applications requiring Class 2 (≤-40°C PDP) or Class 1 (≤-70°C PDP) must deploy desiccant or membrane dryers. These are frequently sequenced downstream of a refrigerated unit, utilising the refrigerant stage for bulk moisture precipitation and the desiccant stage for precision dewpoint polishing. For Class 0 the site validates a custom specification stricter than Class 1.
- Fine particulate filter (Stage 2): removes particles ≥1 µm (ISO 8573-1:2010 Class 2) or ≥0.5 µm (Class 1). Often a coalescing filter that also removes residual oil aerosol.
- Ultra-fine particulate filter (Stage 3, if Class 0 or 1): removes particles ≥0.1 µm. Necessary for strict purity. Media: borosilicate glass or PTFE, with high pressure drop and frequent change intervals.
- Activated carbon filter (if needed): removes residual volatile organic compounds and odours. Optional for Class 2 or 3; standard configuration for Class 0 or 1.
A typical Class 2 system: oil-free compressor → aftercooler → coarse filter → refrigerated dryer (bulk water removal) → desiccant dryer (Class 2 polishing) → fine filter → receiver → piping with point-of-use fine filter.
A typical Class 1 system: oil-free compressor → aftercooler → coarse filter → refrigerated dryer → fine filter → desiccant polishing dryer → activated carbon filter → receiver → piping with point-of-use ultra-fine sterile filter.
Receiver Sizing and Condensate Management
Size the receiver right and it does three jobs for you: storage to buffer demand spikes and reduce compressor unload cycles; cooling to precipitate residual moisture; surge volume for system stabilisation.
Pharmaceutical systems size receivers from the compressor free air delivery (FAD), not motor kW alone. Per the CAS receiver-sizing guideline (receiver volume in litres approximately FAD in L/s × 10 to 15 seconds of dwell), a 15 kW oil-free rotary screw compressor delivering approximately 30 to 40 L/s (1,800 to 2,400 L/min FAD at 7 bar) sits at roughly 300 to 600 L. See the Air Receiver Tanks Australia guide for the full method and the AS 4343:2014 hazard-level assessment that drives state/territory pressure-vessel registration.
Don’t skip the condensate side. Receivers accumulate moisture despite drying; this water must be removed daily (or via automatic float traps). Oil-water separation (coalescing drain traps) is essential because even trace oil plus water forms an acidic sludge that corrodes internal piping and damages downstream equipment.
Piping Material and System Layout
Your piping choice is a contamination decision, not a plumbing one, and it depends on whether the line is in contact with the product or its packaging. For non-contact instrument and plant air, anodised aluminium piping is appropriate and commonly specified. For sterile direct-product-contact gases (for example WFI cover gas, sterile fill, aseptic blanket), 316L electropolished stainless steel with orbital welds is the GMP default because it can be steam-sterilised in place and resists biofilm accumulation; aluminium is not suitable for these lines. Black iron piping is acceptable only for non-pharmaceutical facility air. Internal surface roughness must be minimised to prevent particle trapping and biofilm formation.
System layout must minimise pressure drop (typically designed for under 0.5 bar drop across the distribution network) and include:
- Isolating block valve at compressor discharge
- Non-return (check) valve to prevent backflow during shut-down
- Pressure relief valve set so its set pressure does not exceed the vessel’s design (maximum allowable) pressure, as marked on the vessel and the valve, rather than at a fixed percentage above operating pressure
- Pressure gauge and dew point monitoring point upstream of receiver
- Drain valve (with float trap or automatic solenoid) at receiver low point
- Secondary regulator and filter at each critical use point
Validation and In-Service Testing
Validation is what turns your system from “installed” into “defensible at audit.” TGA GMP requires documented validation under PIC/S Annex 15 at three stages:
Installation Qualification (IQ)
Verify that the installed system matches the design specification (compressor model, dryer type, filter stages, receiver size, piping material). Documentation must include equipment datasheets, P&ID (piping and instrumentation diagram), weld certifications where applicable, and calibration certificates for all instruments.
Operational Qualification (OQ)
Test the system under normal operating conditions and demonstrate that all parameters (pressure, dew point, flow, particle count, oil content) meet specification. OQ includes:
- Pressure stability test: run at full load for 2 to 4 hours; pressure must remain within ±0.2 bar of setpoint
- Dew point measurement: using calibrated dew point meter; must be ≤ specification
- Particle count test: ISO 8573-4 (optical particle counting) and ISO 8573-8 (mass concentration) as the compressed-air-specific particle measurement standards; results must not exceed the ISO 8573-1:2010 class limits
- Oil content test: ISO 8573-2 (aerosol) plus ISO 8573-5:2025 (vapour) combined for total oil; must not exceed specification
- Flow rate verification: confirm compressor output at stated pressure
Performance Qualification (PQ)
This is where you prove sustained performance under actual production conditions. Performance Qualification (PQ) duration is not prescribed by PIC/S Annex 15. PIC/S Annex 15 places PQ after IQ and OQ and requires tests under normal operating conditions with worst-case batch sizes; the frequency of sampling used to confirm process control should be justified against the site’s risk assessment. The PQ duration is a site-specific qualification deliverable, not a fixed calendar or number of campaigns. Monitoring points include:
- Daily checks: dew point and pressure
- Filter trending: differential pressure trending to detect clogging
- Condensate inspection: colour and odour; should be water only, no oil
- Point-of-use sampling: near critical equipment to confirm air quality at the actual application point
Maintenance, Monitoring and Change Control
Routine Maintenance Schedule
Treat the table below as a starting point, not gospel: the intervals are indicative. Replace filter elements when differential pressure reaches 0.3 bar or at the supplier-specified hour limit, whichever comes first. Dew-point drift outside specification, particle-count exceedance, or visible saturation of a cartridge overrides the scheduled interval. Record the trigger (hours, differential pressure, dew-point alarm, or QA finding) on the change-out log to satisfy GMP traceability.
| Task | Frequency | Rationale | Documentation |
|---|---|---|---|
| Visual inspection of system (leaks, noise, vibration) | Daily | Early detection of mechanical issues | Maintenance log |
| Receiver condensate drain | Daily | Remove accumulated water; prevent corrosion | Drain log (date, volume, appearance) |
| Pressure and dew point check | Daily | Verify system performance within specification | Monitoring sheet |
| Filter element visual inspection | Weekly | Check for saturation, bypass risk | Inspection log |
| Oil-water separator cartridge drain | Weekly or per indicator | Remove separated oil and water | Maintenance record |
| Dryer regeneration (desiccant only) | Per dryer design (typically every 8 to 24 hrs) | Restore desiccant capacity | Dryer run log |
| Compressor oil level and colour check (if applicable) | Monthly (oil-free: N/A) | Detect contamination or leakage | Log |
| Particulate filter element replacement | Every 500 to 1,000 operating hours or per pressure drop | Maintain ISO 8573-1:2010 class specification | Change-out log with element P/N and date |
| Fine filter element replacement | Every 500 to 1,000 operating hours or per pressure drop | Maintain particle purity | Change-out log |
| Desiccant dryer cartridge replacement (if desiccant used) | Every 1,000 to 2,000 operating hours or per dew point drift | Restore drying capacity; prevent moisture breakthrough | Log with cartridge type and installation date |
| Full system dew point and particle count validation | Annually or per change control | Confirm system meets specification; satisfy GMP requirement | Test report with lab accreditation |
| Pressure relief valve certification (external service) | Every 2 to 5 years per regulations | Ensure safety device function | Service certificate |
Monitoring Parameters and Alarm Thresholds
Pharmaceutical systems typically include:
- Pressure gauges: analog or digital, set to alarm if pressure drops more than 0.5 bar below setpoint (indicative of compressor fault or major leak)
- Dew point continuous monitor: early warning of dryer saturation or failure
- Filter pressure drop indicators: alert when cartridge approaches end-of-life
- Condensate drain float trap: automatic drain; overflow alarm if drain becomes blocked
Change Control and Re-Validation
Any modification to the system (new compressor, upgraded filter, dryer replacement, piping extension, etc.) requires a Change Control form detailing:
- Description of change and technical justification
- Impact assessment (does it affect validated air quality?)
- Re-validation scope (IQ/OQ/PQ or subset thereof)
- Approval by Quality Assurance before implementation
- Documentation of testing and results post-change
Most changes require at least OQ re-validation; major changes (new compressor) require full IQ/OQ/PQ. Record retention follows the site quality system and applicable TGA retention requirements for the relevant product class; retention periods vary by product and process risk.
Common Failures and Troubleshooting
When air quality slips, it usually shows up as one of a handful of recurring failure modes. Catch them early on your daily checks and you keep them off your batch records. Here is what to watch for and how to fix it.
| Failure Mode | Cause | Detection Method | Corrective Action |
|---|---|---|---|
| High dew point (moisture breakthrough) | Saturated desiccant dryer, faulty refrigerated dryer, or inadequate cooling | Daily dew point monitor; or wet spots inside piping | Replace dryer cartridge (desiccant) or service dryer (refrigerated); check aftercooler performance |
| Pressure drop below minimum | Compressor failure, major leak in piping, clogged intake filter | Pressure gauge; audible change in compressor sound | Check intake filter first (quick fix); isolate and inspect compressor; leak detection test on piping |
| Visible moisture or oil in receiver | Oil carryover from compressor (should not occur in oil-free unit; indicates seal failure), or inadequate drainage of condensate | Visual inspection during daily drain | For oil-free unit: service compressor seals; increase drain frequency; add secondary oil-water separator if dwell time allows; for condensate: ensure drain is operational and not blocked |
| Particle count exceeding specification | Clogged or degraded filter element, compressor internal wear (shedding particles), or leak in filter housing | ISO 8573-4 particle count test; filter pressure drop gauge | Replace filter element; inspect compressor for internal damage (may require rebuild); check filter housing seals for leaks |
| Compressor unload cycling (pressure rises and falls repeatedly) | Receiver too small, demand spike, dryer restriction, or clogged filter | Pressure gauge observation; compressor load/unload audible cycling | Verify demand is within design; check filter and dryer pressure drop; increase receiver size if demand profile has changed |
| Odour in discharged air (musty, chemical smell) | Microbial growth in receiver (biofilm) or decomposing oil residue | Olfactory during daily inspection; ISO 8573-7 viable microbiological count if biofilm suspected | Flush receiver with hot water or approved cleaning agent; disinfect if necessary; increase drain frequency to prevent stagnant water |
Frequently Asked Questions
What ISO 8573-1 air quality class does TGA require for pharmaceutical compressed air?
TGA does not prescribe an ISO 8573-1 class directly. The class is set inside the site’s PIC/S PE009-17 GMP validation file against the actual product and process. Australian pharmaceutical sites commonly validate to Class 1.2.1 or tighter for parenteral, inhalation, and aseptic processing, Class 2 or 3 for general powder, tablet, and encapsulation operations, and Class 0 (specified stricter than Class 1) for inhalation products and parenteral container wash. The class must be defined in the validated design and tested against in IQ, OQ, and PQ.
Does the TGA mandate a specific compressed air standard?
No. The TGA enforces GMP under the Therapeutic Goods Act 1989 and aligns with the PIC/S PE009-17 guide (TGA-adopted from 1 September 2025). Compressed air is one of the critical utilities covered by the PIC/S Annex 1 utility and Contamination Control Strategy requirements that must be validated, controlled, and monitored. The specific ISO 8573-1 class, sample frequency, and acceptance limits are set by the site’s quality system against the product risk. The Annex 1 (2023 revision) contamination control requirements apply during normal operation and during maintenance.
What validation is required for a pharmaceutical compressed air system?
Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) under PIC/S Annex 15 are required. Suppliers must provide documented evidence of design, testing, and performance against the validated air quality class. Any modification to the system, including a new compressor, filter upgrade, dryer change, or regulator adjustment, requires change control documentation and frequently re-validation. Record retention follows the site quality system and applicable TGA retention requirements for the relevant product class.
Do I need an oil-free compressor for pharmaceutical manufacturing?
For direct-contact air in inhalation, parenteral, or aseptic processing, an oil-free compressor is the safest design because it removes the oil contamination pathway at the source. For indirect-support air on tablet operations, encapsulation, and packaging automation, an oil-injected compressor with multi-stage filtration and validated downstream monitoring can meet the required ISO 8573-1 class at lower capital cost provided the achieved oil content is verified per ISO 8573-2 and ISO 8573-5:2025. The decision is risk-based and must be supported by the validation file and the Contamination Control Strategy under Annex 1.
What test methods apply to pharmaceutical compressed air?
Use the ISO 8573 series test methods for compressed air: ISO 8573-4 (optical particle counting) and ISO 8573-8 (mass concentration) for solid particles; ISO 8573-3 for water vapour humidity; ISO 8573-2 (aerosol) plus ISO 8573-5:2025 (vapour) combined for total oil; ISO 8573-7 for viable microbiological CFU. ISO 11171 is the hydraulic-fluid power particle counting standard and is not applicable to compressed-air gas-phase particle measurement. ISO 12500 is the compressed-air filter performance test family and is not a microbial method.
What are the most common compressed air audit findings in Australian pharmaceutical facilities?
The recurring non-conformances are no documented ISO 8573-1 class in the validated design, overdue filter element replacement, missing or incomplete air quality test records (especially for particles and microbiological parameters), no corrective action procedure for failed tests, and undocumented equipment changes (compressor or filter stage modification without change control and re-validation). All are preventable through a structured compressed air management programme that ties the validated class to scheduled monitoring and to GMP change control.
Sourcing pharmaceutical compressed air systems
What to send us. Facility category (oral solid dose, sterile injectables, biotech, API manufacturing, packaging), your CCS/QRM status (PIC/S aligned with formal CCS, GMP scope no formal CCS, outside GMP scope, or unsure), the air streams in scope (process, instrument, blanket/inert gas, or multiple), your state and suburb, current compressor make if any, and a one-line description of what’s prompting the call (PIC/S audit finding, new facility fitout, classification review, equipment replacement). Acknowledgement within one business day. Regime-matched supplier shortlist or status update within five business days.
Related Resources
- Air Compressors Australia: equipment types and selection guidance
- Oil-Free Compressors: design, benefits, and industrial applications
- Compressed Air Filtration: particle removal, coalescing filters, and activated carbon
- Compressed Air Dryers and Air Quality: dew point control, moisture management, and dryer selection
- Food Processing Industry: related GMP and FSANZ regulatory frameworks
- Medical and Dental Air Systems: AS 2896:2021 and AS 2568:2019 requirements
- Compressed Air Piping and Distribution: materials, layout, and pressure drop
- Compressed Air Leak Detection: maintaining system integrity
- Energy Audit Guide: optimising compressed air energy consumption
- Compressed Air Systems Guide: system design fundamentals
- All Industry Solutions: explore compressed air applications across sectors
- TGA Pharmaceutical Compressed Air Compliance: regulatory requirements, ISO 8573-1 classes, and validation for TGA GMP manufacturing
- Leak Cost Calculator: estimate the annual electricity cost of compressed air leaks by size and pressure
- Dew point calculator: Size dryers to ISO 8573-1:2010 Class 2 water for pharmaceutical manufacturing
- Air Receiver Tanks for Pharmaceutical Compressed Air: receiver sizing + AS 4343:2014 hazard level + state WHS registration pathway
General information disclaimer. The information on this page is general in nature and provided for educational purposes only. It is not engineering, safety, or professional advice, and it does not account for the specifics of your site, equipment, or duty. Compressed air system design, pressure equipment selection, and regulatory compliance must be confirmed with a qualified engineer and the relevant work health and safety regulator before you act. Compressed Air Solutions is a publisher and referral service, not a licensed engineering practice, and accepts no liability for decisions made on the basis of this content. Verify all figures, standards references, and regulatory requirements against current primary sources.